Post by Basilea Pharmaceutica
24,547 followers
500’000 patients treated worldwide. 70+ countries reached. Now writing the next chapter of growth. More than half a million patients have been treated with our medicines since launch, with our products now available in more than 70 countries worldwide. At Basilea’s Capital Markets Day 2026, Basilea will provide further insights into our future portfolio development, strategic priorities, and the next phase of growth across our anti-infectives business. #CapitalMarketsDay #AntiInfectives #HealthcareInnovation
Video Content